发明名称 |
SUSTAINED RELEASE FORMULATION OF NALTREXONE |
摘要 |
A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition. |
申请公布号 |
US2016158225(A1) |
申请公布日期 |
2016.06.09 |
申请号 |
US201615046373 |
申请日期 |
2016.02.17 |
申请人 |
Orexigen Therapeutics, Inc. |
发明人 |
McKinney Anthony A.;Tollefson Gary D.;Soltero Richard;Dunzo Thea Elise |
分类号 |
A61K31/485;A61K9/00;A61K31/137 |
主分类号 |
A61K31/485 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
La Jolla CA US |